We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos Initiates Clinical Studies with GLPG0187, a Candidate Drug for Bone Metastasis

News   Jun 17, 2009

 
Galapagos Initiates Clinical Studies with GLPG0187, a Candidate Drug for Bone Metastasis
 
 
 

RELATED ARTICLES

Temperature-stable Tuberculosis Vaccine Enters Clinical Testing

News

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

READ MORE

Secret Immune Response Role for Common Metabolites

News

Researchers identify the molecules responsible for inducing intestinal immune cells to extend tentacle-like structures, known as dendrites, to “capture” antigens, triggering both immediate and long-term immune responses.

READ MORE

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE